EGFR and lung carcinoma: Given the complexity of lung cancer’s molecular biology, it may be of interest to analyze additional galectins, as well as other relevant lung cancer biomarkers such as ALK, TP53, and EGFR, simultaneously, to gain deeper insights into their implications in lung cancer.